1984•Journal of Pediatric Hematology/OncologyRequires access

Dr. James A. Wolff. I. Early progress in treatment of Rh hemolytic disease

Carl Pochedly

Open publisher page 0 citations

Abstract

Dr. James Wolff's interest in hematology began while he was assigned on the transfusion service in a field hospital in the European Theatre during World War II. His interest was increased during his pediatric residency at the Boston Children's Hospital (1945-1947). At that time, Dr. Louis Diamond was involved in his important studies on treatment of erythroblastosis fetalis by exchange transfusion. Drs. Farber and Diamond were also involved with the initial clinical trials of aminopterin for the treatment of acute leukemia. The concept of treating erythroblastosis fetalis by exchange transfusion grew from our understanding of the pathophysiology of this disease, as first explained by Philip Levine and Alexander Wiener. Three techniques of exchange transfusion were tried. Diamond's umbilical catheter technique, because of its relative ease and simplicity and because it could be used for multiple exchanges, soon became the accepted method for treating infants with erythroblastosis fetalis.

About this research paper

What this paper is about

Dr. James Wolff's interest in hematology began while he was assigned on the transfusion service in a field hospital in the European Theatre during World War II. His interest was increased during his pediatric residency at the Boston Children's Hospital (1945-1947). At that time, Dr. Louis Diamond was involved in his important studies on treatment of erythroblastosis fetalis by exchange transfusion. Drs. Farber and Diamond were also involved with the initial clinical trials of aminopterin for the treatment of acute leukemia. The concept of treating erythroblastosis fetalis by exchange transfusion grew from our understanding of the pathophysiology of this disease, as first explained by Philip Levine and Alexander Wiener. Three techniques of exchange transfusion were tried. Diamond's umbilical catheter technique, because of its relative ease and simplicity and because it could be used for multiple exchanges, soon became the accepted method for treating infants with erythroblastosis fetalis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Dr. James Wolff's interest in hematology began while he was assigned on the transfusion service in a field hospital in the European Theatre during World War II. His interest was increased during his pediatric residency at the Boston Children's Hospital (1945-1947). At that time, Dr. Louis Diamond was involved in his important studies on treatment of erythroblastosis fetalis by exchange transfusion. Drs. Farber and Diamond were also involved with the initial clinical trials of aminopterin for the treatment of acute leukemia. The concept of treating erythroblastosis fetalis by exchange transfusion grew from our understanding of the pathophysiology of this disease, as first explained by Philip Levine and Alexander Wiener. Three techniques of exchange transfusion were tried. Diamond's umbilical catheter technique, because of its relative ease and simplicity and because it could be used for multiple exchanges, soon became the accepted method for treating infants with erythroblastosis fetalis.

Key concepts: Medicine, Erythroblastosis fetalis, Exchange transfusion, Hemolytic disease of the newborn (ABO), Hydrops fetalis, Pediatrics, Intensive care medicine, Pregnancy

Related papers

Back to paper searchBrowse research topicsOriginal source
Dr. James A. Wolff. I. Early progress in treatment of Rh hemolytic disease — Research Paper | ScholarLens